Search Tag: Maplight Therapeutics
2023 24 Jul
MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted, novel therapeutics to improve the lives of people with brain disorders announced the appointment of Tim Garnett, M.D. to its Board of Directors. Dr. Garnett is a pharmaceutical executive with decades of experience in drug development and strategic portfolio...Read more
2023 11 Apr
Executive with 25+ Years of Neuroscience-focused Commercialization Experience To Lead Commercial Strategic Development Across the Company's Pipeline of CNS Assets MapLight Therapeutics, a clinical-stage biopharmaceutical company developing targeted, highly effective therapeutics to improve the lives of those with difficult-to-treat brain disorders announced...Read more